IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Gross margin 2023–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) gross margin by fiscal year — reported gross profit divided by reported revenue.
34.3%FY2025 · since FY2023: 13.1% → 34.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 34.3% | -8.9 pp |
| FY2024 | 43.2% | +30.0 pp |
| FY2023 | 13.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IOVA financial trends
IOVA RevenueIOVA Net incomeIOVA Net marginIOVA Gross profitIOVA Operating incomeIOVA Operating marginIOVA Operating cash flowIOVA Free cash flowIOVA Capital expendituresIOVA Return on equityIOVA Stock buybacksIOVA Dividends paidIOVA Total assetsIOVA Total liabilitiesIOVA Shareholders’ equityIOVA overview →